Rilpivirine 70069-0848-30
- Manufacturer
- Somerset Therapeutics, Llc
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- January 30, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA218798
Need to source Rilpivirine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Rilpivirine Hydrochloride | 25 mg/1 |
Drug Class
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Non-Nucleoside Analog [EXT]Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
Selected Package
70069-0848-30Selected30 TABLET, FILM COATED in 1 BOTTLE (70069-848-30)